e-learning
resources
Stockholm 2002
Monday 16.09.2002
Pulmonary thromboembolism and pulmonary hypertension
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
New aspects of pharmacological correction of pulmonary hypertension in COPD patients
R. R. Frangulyan (Yerevan, Armenia)
Source:
Annual Congress 2002 - Pulmonary thromboembolism and pulmonary hypertension
Session:
Pulmonary thromboembolism and pulmonary hypertension
Session type:
Poster Discussion
Number:
1538
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. R. Frangulyan (Yerevan, Armenia). New aspects of pharmacological correction of pulmonary hypertension in COPD patients. Eur Respir J 2002; 20: Suppl. 38, 1538
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Conclusion: treatment of pulmonary hypertension in COPD patients
Source: Annual Congress 2005 - COPD - pulmonary haemodynamics and gas exchange
Year: 2005
Does pulmonary hypertension exclude pulmonary rehabilitation in patients with COPD?
Source: International Congress 2017 – Best abstracts in pulmonary rehabilitation in patients with chronic lung diseases
Year: 2017
The effectiveness of pulmonary rehabilitation in Russian patients with COPD complicated by pulmonary artery hypertension
Source: Annual Congress 2009 - Pulmonary rehabilitation: extending the scope and benefit of rehabilitation for patients with chronic respiratory disease
Year: 2009
Diagnosis and treatment of secondary pulmonary hypertension in patients with COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 404s
Year: 2006
microRNA profile in COPD patients with and without pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH
Year: 2015
Effects of different classes of bronchodilators on pulmonary hemodynamics in patients with chronic obstructive pulmonary disease>
Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies
Year: 2019
Influence of bronchodilators on pulmonary hypertension in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2003; 22: Suppl. 45, 427s
Year: 2003
NT-proBNP in assessment of pulmonary hypertension in COPD patients
Source: Annual Congress 2013 –COPD treatment
Year: 2013
Pharmacological therapy for patients with chronic thromboembolic pulmonary hypertension
Source: Eur Respir Rev 2015; 24: 272-282
Year: 2015
Update on current treatment options of pulmonary hypertension
Source: Annual Congress 2006 - Pulmonary hypertension at the crossroads of science and clinical medicine
Year: 2006
New markers of endothelial dysfunction in patients with bronchial asthma with and without pulmonary hypertension
Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous
Year: 2008
Evaluation of criteria for exercise-induced pulmonary hypertension in patients with resting pulmonary hypertension
Source: Eur Respir J, 50 (3) 1700784; 10.1183/13993003.00784-2017
Year: 2017
Need for generalized criteria in evaluating the impact of new drugs in clinical trials involving patients suffering from COPD
Source: Annual Congress 2006 - Outcomes for COPD pharmacological trials: from lung function to biomarkers
Year: 2006
Effects of pulmonary rehabilitation on different outcomes and at different times in subjects suffering from stable COPD
Source: Annual Congress 2006 - Outcomes in pulmonary rehabilitation
Year: 2006
Treatment options for paediatric pulmonary arterial hypertension
Source: Eur Respir Rev 2010 19: 321-330
Year: 2010
Effects of Valsartan on pulmonary hemodynamics in patients with chronic obstructive pulmonary disease (COPD) and secondary pulmonary hypertension
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019
Gender-related differences in pulmonary hemodynamics in patients with end-stage COPD
Source: Annual Congress 2005 - COPD - pulmonary haemodynamics and gas exchange
Year: 2005
Early diagnostic evaluation of pulmonary hypertension in severe COPD patients (preliminary results)
Source: Eur Respir J 2006; 28: Suppl. 50, 657s
Year: 2006
Echocardiographic assessment of cardiac function in patients with chronic obstructive pulmonary disease
Source: International Congress 2015 – COPD: interesting notes
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept